Technology platforms
The strong partnership policy set in place by the Life Sciences Division ensures better research coordination, networking of skills and optimisation of resources. This policy has in particular resulted in the setting up of technical facilities and centres of excellence.
In vivo imaging platforms
In vivo imaging platforms in the Paris Region. Along with other research agencies, the Life sciences division is complementing the technical resources located in the Paris area (and including the imaging facilities of the Service Hospitalier Frédéric Joliot in Orsay) with two new imaging platforms, thus taking an active part in the formation of an European centre of excellence.
Platform for biochips
A platform for the production of DNA chips and platforms for the development of new types of biochips.
Proteomics technological platform
A proteomics platform at the Rhône-Alpes Genopole, which develops new methodological approaches for the micro-analysis of proteins and ensures proteomics analysis through several local, regional and national collaborations (Génoplante and GenHomme programmes).
Screening facilities for bioactive molecules
A combinatorial chemistry (Île-de-France region) and high-throughput screening facility (Grenoble, Île-de-France region)
Biochemistry for post-genomics
A post-genomics biochemistry platform in Marcoule, which ensures high output production of candidate proteins for functional or structural studies
Structural biology platform
A structural biology facility associating a technical facility with methodological development in crystallography, NMR, mass spectrometry, electronic microscopy, optical methods and molecular simulation.
Infrastructures for research in radiobiology and nuclear toxicology
Infrastructures for research in radiobiology and nuclear toxicology: a radiation platform optimised for low doses (Fontenay aux Roses) , infrastructures for in vivo studies on actinides (Bruyères le Chatel).
Phytotechnology platform
This platform is dedicated to the development and the use of an innovative and a complete set of ultra-controlled greenhouses for plant culture and study. The platform belongs to the « Groupe de Recherches Appliquées en Phytotechnologie (GRAP) » lab and is located at the CEA/iBEB institute (Cadarache).
Infrastructures for research on prion diseases
High-safety infrastructure – Level 3 laboratories and animal houses installed in the Île-de-France region are used for the study and handling of biological agents that are pathogenic for animals or humans. They are dedicated in particular to research on prion diseases and the AIDS virus.
Flow Cytometry and cell sorting platforms
The institutes for Emerging diseases and innovative therapies (iMETI) and for Radiobiology, cellular and molecular biology (iRCM) possess two platforms for flow cytometry and cell sorting opened to industrial and academical partners depending on their particular needs and projects thematics in the framework of collaborative research.
Furthermore, the FlowCyTech so-called iMETI's cytometry platform, organizes an European School of cytometry (FlowSchool) opened to investigators.
Furthermore, the FlowCyTech so-called iMETI's cytometry platform, organizes an European School of cytometry (FlowSchool) opened to investigators.